Epidarex Capital Investor

Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capital’s investors represent a cross-section of leading universities, international corporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities.
Industry: Personalized Medicine
Headquarters: Bethesda, Maryland, United States
Founded Date: 2010
Employees Number: 1-10
Funding Status: N/A
Investor Type: Venture Capital
Investment Stage: Early Stage Venture
Number Of Exits: 2

Visit Website
Register and Claim Ownership